Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\HSP90.php on line 2
HSP90
LE WE PMID CA
HSP901226HSP90

4 Hydroxynonenal

Alcohol

alpha Crystallin

Angiogenesis

Apoptosis

Cell differentiation

CHIP (Protein)

Cisplatin

DNA (Repair and Toxicology)

Efrapeptins

FKBP51

FKBP52

Genetics (Transposon)

Heat shock proteins

HIF1alpha und HIF1 (BASKET)

HSP27

HSP70

HSP90

Immunophilin

Natural products

Neoplasia (Invasion and metastasis)

Neurodegeneration

p23

Proteasome (BASKET)

Proteasome (Pharmacology)

Protein (protein binding)

Protein disulfide isomerase

RACK1

Receptor (Nuclear)

Signal transduction

Telomere

Transporter (Proton)

2007  
1
Heat shock protein 90: the cancer chaperone.
[17536171] J Biosci 32(3): 517-30 (2007)
2006  
2
Hsp90 at the crossroads of genetics and epigenetics.
[16940964] Cell Res 16(9): 742-9 (2006)
2009  
3
The Hsp90 chaperone machinery: from structure to drug development.
[19874705] BMB Rep 42(10): 623-30 (2009)
2004  
4
Altered Hsp90 function in cancer: a unique therapeutic opportunity.
[15299085] Mol Cancer Ther 3(8): 1021-30 (2004)
2007  
5
Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells.
[17363512] Clin Cancer Res 13(6): 1625-9 (2007)
2007  
6
Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis.
[17645779] Cancer Sci 98(10): 1536-9 (2007)
2001  
7
Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.
[11599571] Cell Stress Chaperones 6(2): 105-12 (2001)
2006  
8
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors.
[17259553] Endocr Relat Cancer 13 Suppl 1(-): S125-35 (2006)
2003  
9
The Hsp90 chaperone complex as a novel target for cancer therapy.
[12881371] Ann Oncol 14(8): 1169-76 (2003)
2010  
10
Hsp90 inhibitors: a potential treatment for latent EBV infection?
[20404505] Cell Cycle 9(9): 1665-6 (2010)
2004  
11
Hsp90 activation and cell cycle regulation.
[15539946] Cell Cycle 3(12): 1530-6 (2004)
2007  
12
Heat shock protein 90: a potential therapeutic target in leukemic progenitor and stem cells harboring mutant BCR-ABL resistant to kinase inhibitors.
[17671436] Cell Cycle 6(18): 2227-31 (2007)
2007  
13
Hsp90 and the Fanconi anemia pathway: a molecular link between protein quality control and the DNA damage response.
[17881891] Cell Cycle 6(18): 2232-5 (2007)
2007  
14
RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization.
[17361105] Cell Cycle 6(6): 656-9 (2007)
2008  
15
Twin layers of lightning: a new role for the chaperone Hsp90 in angiogenesis.
[17975116] Arterioscler Thromb Vasc Biol 28(1): 6-7 (2008)
2008  
16
The Hsp90 chaperone machinery regulates signaling by modulating ligand binding clefts.
[18515355] J Biol Chem 283(34): 22885-9 (2008)
2010  
17
Heat shock proteins: cell protection through protein triage.
[20694452] ScientificWorldJournal 10(-): 1543-52 (2010)
2010  
18
Is canalization more than just a beautiful idea?
[20236474] Genome Biol 11(3): 109 (2010)
2009  
19
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models.
[19416831] Proc Natl Acad Sci U S A 106(20): 8368-73 (2009)
2009  
20
Heat shock protein 90 as a drug target: some like it hot.
[19118027] Clin Cancer Res 15(1): 9-14 (2009)
2009  
21
Targeting HSP90 for cancer therapy.
[19401686] Br J Cancer 100(10): 1523-9 (2009)
2010  
22
Mitochondrial Hsp90 chaperones as novel molecular targets in prostate cancer.
[20373861] Future Oncol 6(4): 487-9 (2010)
2009  
23
Impact of heat-shock protein 90 on cancer metastasis.
[19519207] Future Oncol 5(5): 679-88 (2009)
2010  
24
2008  
25
Targeting Hsp90: small-molecule inhibitors and their clinical development.
[18644253] Curr Opin Pharmacol 8(4): 370-4 (2008)
2011  
26
Antitumor activity of efrapeptins, alone or in combination with 2-deoxyglucose, in breast cancer in vitro and in vivo.
[20927616] Cell Stress Chaperones 16(2): 181-93 (2011)
2011  
27
Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease.
[21354120] Chem Biol Interact 192(1-2): 107-12 (2011)
2008  
28
Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.
[18991631] Curr Med Chem 15(26): 2702-17 (2008)
2010  
29
2009  
30
Discovery and development of heat shock protein 90 inhibitors.
[19017562] Bioorg Med Chem 17(6): 2225-35 (2009)
2009  
31
Natural product inhibitors of Hsp90: potential leads for drug discovery.
[19200020] Mini Rev Med Chem 9(2): 140-52 (2009)
2010  
32
Heat shock protein 90 in neurodegenerative diseases.
[20525284] Mol Neurodegener 5(-): 24 (2010)
2007  
33
Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27.
[19164900] Prion 1(1): 53-60 (2007)
2011  
34
FKBP immunophilins and Alzheimer's disease: a chaperoned affair.
[21799260] J Biosci 36(3): 493-8 (2011)
2008  
35
Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions.
[18451092] Mol Endocrinol 22(10): 2229-40 (2008)
2003  
36
p23, a simple protein with complex activities.
[14627195] Cell Stress Chaperones 8(2): 108-13 (2003)
2003  
37
CHIP: a link between the chaperone and proteasome systems.
[15115282] Cell Stress Chaperones 8(4): 303-8 (2003)
2007  
38
Hsp90--from signal transduction to cell transformation.
[17826744] Biochem Biophys Res Commun 363(2): 241-6 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\HSP90.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\HSP90.php on line 92